Indivior Pharmaceuticals (INDV) Research & Development (2022 - 2025)
Historic Research & Development for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $33.0 million.
- Indivior Pharmaceuticals' Research & Development rose 5000.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 1739.13%. This contributed to the annual value of $107.0 million for FY2024, which is 775.86% down from last year.
- As of Q3 2025, Indivior Pharmaceuticals' Research & Development stood at $33.0 million, which was up 5000.0% from $21.0 million recorded in Q2 2025.
- Indivior Pharmaceuticals' 5-year Research & Development high stood at $33.0 million for Q3 2025, and its period low was -$38.0 million during Q4 2024.
- Its 4-year average for Research & Development is -$4.0 million, with a median of -$16.0 million in 2022.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Research & Development plummeted by 12857.14% in 2023, and later skyrocketed by 22222.22% in 2024.
- Over the past 4 years, Indivior Pharmaceuticals' Research & Development (Quarter) stood at -$29.0 million in 2022, then fell by 3.45% to -$30.0 million in 2023, then decreased by 26.67% to -$38.0 million in 2024, then surged by 186.84% to $33.0 million in 2025.
- Its Research & Development stands at $33.0 million for Q3 2025, versus $21.0 million for Q2 2025 and $22.0 million for Q1 2025.